Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Urchin Capital Partners is a private investment firm that focuses on identifying and supporting high-growth opportunities across various sectors, with a significant emphasis on the life sciences and healthcare industries. The firm operates as a family office or private equity vehicle, providing strategic capital to emerging biotechnology and medical technology companies. Urchin Capital Partners typically engages in early-to-mid-stage financing, leveraging its expertise to help portfolio companies navigate clinical development and commercialization. While the firm maintains a diversified portfolio, its healthcare investments often target innovative therapeutic platforms and medical devices. The firm is known for its long-term investment horizon and hands-on approach to value creation within its partner companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Urchin Capital Partners.